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Background: There is urgent need to discover new antimicrobial compounds with diverse chemical structures and
mechanisms of action due to increasing new and re-emerging infectious diseases. Additionally, appearance of
undesirable side effects of certain antibiotics and increasing resistance to antibiotics in current clinical use is also a
cause for concern. Bacterial cell membranes are a possible target for developing new antibacterial drugs since
membrane-based efflux pump systems play an important role in bacterial pathogenicity and antimicrobial resistance
in bacteria. Hence, the objective of our study was to evaluate bacterial membrane integrity of two species of
bacteria; Staphylococcus aureus and Pseudomonas aeruginosa, in the presence of ethanolic leaf extracts of two plant
species Callistemon citrinus and Vernonia adoensis from Zimbabwe.
Methods: Bacterial efflux pump inhibition using both leaf extracts was determined by monitoring the transport
of Rhodamine 6 G (R6G) across the cell membrane and IC50 values were obtained. Membrane permeabilizing
properties of both extracts were also evaluated using the membrane potential sensitive dye 3’3
dipropylthiadicarbocyanine (diSC3-5). Haemolysis effect of both extracts on sheep erythrocytes was also
investigated.
Results: Both extracts inhibited bacterial efflux pumps which resulted in the accumulation of R6G inside
the cell. The IC50 values for C. citrinus and V.adoensis against S. aureus were 1.44 mg/ml and 1.61 mg/ml,
respectively. Both leaf extracts however, showed similar IC50 values of 1.64 mg/ml against P. aeruginosa. Both
plant extracts showed some significant effects on permeability of the bacterial membrane when a 24-28% increase
of diSC3-5 dye release was observed for S. aureus and 45–53% of dye was released from P. aeruginosa cell membrane
after a 60 minute incubation period. In addition, both extracts exhibited haemolytic effects on sheep erythrocytes at
concentrations greater than 2.5 mg/ml.
Conclusions: These plant extracts may provide new lead compounds for developing potential efflux pump inhibitors
(EPIs) or permeabilising agents that could aid the transport of antibacterial agents into bacterial cells.
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Bacterial infections account for a significant proportion
of the global infectious disease burden hence giving a
negative impact on human welfare and the economy [1].
Morbidity and mortality rates caused by infectious mi-
crobial agents have been shown to pose serious public
health concerns. Throughout the world, about 50–75%
of hospital deaths were reported due to infectious dis-
eases [2]. These numbers continue to increase due to* Correspondence: smukanganyama01@gmail.com
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this article, unless otherwise stated.development of resistance in microorganisms against the
existing first line drugs. Thus, it is critical that a clear
understanding of the biological aspects of infectious dis-
ease be made known so that eventually infectious disease
morbidity and mortality are curtailed, if not eventually
eradicated [3]. The human-mediated use and abuse of
classical antibiotics has created a strong selective pres-
sure for the rapid evolution of antibiotic resistance. As
resistance levels rise, the efficacy of classical antibiotics
wanes. Bacterial drug resistance is emerging as one of
the most significant challenges to human health [4].
Multi-drug resistant microbial infections caused bynsee BioMed Central Ltd. This is an Open Access article distributed under the
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Enterococcus faecalis represent an exponentially growing
problem affecting communities worldwide [5].
Efflux pump-mediated resistance to single or multiple
antimicrobial agents has not only raised serious concerns
but also has constricted the treatment options against
bacterial infections. Efflux pumps reduce the accumu-
lation of antibiotics inside of the bacterial cells, and the
slow phase in which the process of antibiotic efflux takes
place provides sufficient time for the bacterium to adapt
to the antibiotics and become resistant through mutations
or alteration of antibiotic targets [3]. Due to the develop-
ment of this resistance in human pathogens against com-
monly used antibiotics, it has become necessary to search
for new antimicrobial substances from other sources in-
cluding plants [6].
The use of medicinal plants as a source for relief from
illness is doubtless an art as old as mankind [7]. Plants
are the richest resource of drugs of traditional systems
of medicine, modern medicines, nutraceuticals, food sup-
plements, folk medicines, pharmaceutical intermediates
and chemical entities for synthetic drugs [8]. Plants have
been known to synthesize a variety of compounds to pro-
tect themselves against a variety of their own pathogens
and, therefore, can be considered as potential source of
different classes of antimicrobial substances [6].
Callistemon citrinus (Linn.), commonly known as ‘Crimson
Bottle Brush’, is an evergreen tree or shrub, belonging to
the family Myrtaceae [7]. The species of this genus are
mostly used for ornamental purpose. However, Calliste-
mon spp. are also sources of insecticidal, antibacterial and
antifungal bioactive compounds [9]. Callistemon citrinus
grows up to 6–15 m in height and 1.3-1.5 m in girth with
sharp pointed mid-green leaves [7]. The different parts
of this herb have been used in common remedies for
treatment of diarrhoea, dysentery and rheumatism. The
plant is also used as a water accent, anti-cough, anti-
bronchitis and insecticide in folk medicine. Phytochemi-
cally, the plant is rich in polyphenols and essential oils
such as a-pinene, b-pinene, a-terpinene, 1, 8-cineole, linalool,
trans-pinocarveol, terpinen-4-ol, geranioland a-terpineol
that has showed antibacterial activities [7,9]. Vernonia
adoensis is used traditionally by many communities to
treat various illnesses due to lack of resources to access
hospitals or even preference of the use of medicinal plants.
The plant roots are used mainly for the treatment of sexu-
ally transmitted gonorrhoea by people in the Rift valley
and Western part of Kenya [10]. The plant leaves are used
in the treatment of malaria. The decoction of the roots
mixed with the bark of other trees is used in the treatment
of heart and kidney problems. Another study showed very
high anti-plasmodia activity and the leaves are used to
treat T.B. Much research has not being done to test the
phytochemical analysis of this plant [10].Bacterial cell membranes can be used as a target for the
development of new antibacterial drugs. Many plants pro-
duce secondary metabolites which contain a steroid or tri-
terpernoid aglycon attached to one or more sugar chains
that exhibit cell membrane permeabilizing properties [11].
Permeability enhancers are agents that decrease or remove
extra cellular layer resistance reversibly and allow the drug
to pass through. Hence there is a pivotal relationship be-
tween permeability and enhancement activity and toxicity
of the drug since there is easy passage into the cell. More-
over, the permeability enhancing effect of surfactants such
as saponins is not only related to their nature, but also de-
pends on other characteristics like electrical charge, polar-
ity and the membrane [11]. Evaluating the permeability
of enhancers using biological membranes plays an im-
portant role.
Initial screening results showed that leaf extracts from
C. citrinus and V. adoensis were potent antibacterials with
bactericidal activities at low concentrations of 250 μg/ml
and 500 μg/ml, respectively [12]. Furthermore, EPI proper-
ties were also displayed by both extracts, making them po-
tential sources of lead compounds for the development of
new antibacterial agents. Moreover, these findings provided
a basis to further investigate the potential target for the
plant extracts responsible for the antibacterial activities. In
this current study, the bacterial membrane was investi-
gated as a potential antimicrobial target. The concentration
required for 50% inhibition (IC50) of efflux activity in
S. aureus and P. aeruginosa was determined for both plant
extracts by monitoring the transport of Rhodamine 6 G
across the cell membrane. Furthermore, the cytoplasmic
membrane permeabilising properties of the extracts were
also investigated. Plant compounds that could permeabilise
bacterial membranes would be useful in the fight against
bacterial infections since a weakened bacterial membrane
would provide an easy passage of antibiotics into the bac-
terial cell. Finally, membrane haemolysing properties of
the extracts were tested on sheep erythrocytes in order to
determine the concentrations of the extracts that are safe
to use without being toxic to the human body.
Methods
Plant material
C. citrinus was collected at the University of Zimbabwe
campus in Harare province and V. adoensis was collected
from Mashonaland Central (Centenary). This current study
is a follow up on the previously reported antibacterial ac-
tivity of the two extracts. The authentication and voucher
specimen deposits were as reported in Chitemerere and
Mukanganyama [12].
Preparation of extracts
The preparation of plant extracts was described by Chitemerere
and Mukanganyama [12]. Briefly, plant samples were ground
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Vernon Hills, USA). A volume of 8 ml of ethanol was
added to 2 g of grounded powder and shaken for 5 min
on a vortex mixer and left for 10 min. The plant sus-
pension was then transferred into a syringe and filtered
into a small glass vial. The sterile suspension was filtered
again using 0.45 μM Millipore sterile filter (Sigma-Aldrich,
Taufkirchen, Germany) into a labelled small glass vial.
Ethanol was left to evaporate overnight in fume hood with
an air stream. A constant dry weight of each extract was
obtained and the residues were stored at 4°C.
Materials
All the chemicals, including ethanol, dimethylsufoxide (DMSO),
rhodamine 6G (R6G), reserpine, 3,3’-dipropylthiadicarbocyanine
DiSC3(5) iodide, phosphate buffered saline (PBS) and so-
dium azide (NaN3) were purchased from Sigma Chemical
Co. (Taufkirchen, Germany) and all the solvents used were
of analytical grade. Sheep erythrocytes were collected from
the animal house at the University of Zimbabwe.
Microorganisms and growth conditions
A Gram-positive and a Gram-negative bacterial strain;
Staphylococcus aureus (ATCC 9144) and Pseudomonas
aeruginosa (ATCC 27853), respectively were obtained from
the Division of Microbiology, Department of Biological
Sciences, University of Botswana. All strains were main-
tained in 50% glycerol in Eppendorf® microtubes and kept
at −30°C until use. Prior to use, bacteria were grown in
nutrient broth at 37°C for 24 h.
Rhodamine 6G uptake
The concentration at which extracts of the two plant
species inhibited the activity of bacterial efflux pumps by
50% (IC50) was determined in R6G accumulation experi-
ments using the method of Maesaki et al. [13] with some
modifications. Rhodamine 6 G is a fluorescent dye which
is a substrate of efflux pumps and it is used a model for
an antibiotic in this study. Bacteria were cultured over-
night at 37°C at 110 rpm with constant shaking. After
24 h, cells were centrifuged using a Rotofix 32 centrifuge
(Hettich Zentrifugen, Tuttlingen, Germany) at 4000 rpm
for 5 min and washed twice with PBS (pH 7.2). Cells
were centrifuged again and re-suspended at 40 mg/ml in
PBS containing 10 mM NaN3. R6G was added to a final
concentration of 10 μm and cells placed in an incubator
for 1 h. Cells were centrifuged for 5 min at 4000 rpm
and re-suspended in PBS containing 1 M glucose. The
cells were divided into aliquots. Plant extract was then
serially diluted in the range 3.84 mg/ml - 0 mg/ml and
added to the cells. All tubes containing cells and the
extracts at different concentrations were then placed in
an incubator with agitation for 30 min at 37°C. Cells
were centrifuged and the supernatant was discarded. Theremaining pellet was re-suspended in 0.1 M glycine-HCl
(pH 3) and placed in a shaking incubator overnight. After
24 h, cells were centrifuged for 10 min at 4000 rpm and
the supernatant collected for measuring absorbance at
527 nm using an ELISA plate reader. Reserpine, a stand-
ard plant-based EPI, was used as a positive control.
Cytoplasmic membrane permeability assay
The method of Nusslein et al. [4] was used to investigate
the cytoplasmic membrane permeabilizing properties of the
extracts of C. citrinus and V. adoensis against bacterial cell
membranes using disC3-5. Bacterial cells were grown to
mid-exponential phase and collected by centrifugation.
Cells were washed once with buffer (5 mM HEPES, pH 7.2,
5 mM glucose) and re-suspend to 40 mg/ml in buffer.
Cells were then incubated with 1 μM diSC3-5 for 1 hour,
for maximal uptake of dye. Afterwards, 100 mM KCl was
added to equilibrate the cytoplasmic and external K+ ion
concentrations. Cells were then mixed with the desired
concentration of the permeabilizing agent (plant extract
500 μg/ml) and the fluorescence was monitored at an
excitation wavelength of 622 nm and an emission wave-
length of 670 nm. Dye released with the addition of 1%
DMSO was monitored as a positive control while ethanol
was used as a negative control since the plant extracts
were dissolved in ethanol. The monitoring period was for
1 hour at 10 minute intervals. During the assay, 750 μl of
sample were withdrawn at 10 minute intervals and placed
in eppendorf tubes with 750 μl of HEPES buffer. Samples
were then centrifuged and the supernatants were col-
lected for measuring fluorescence using the spectroflouro-
photometer (Shimadzu spectrofluorophotometer, RF-1501,
Shimadzu Corporation, Kyoto, Japan).
Haemolysis assay
Haemolysis assay was carried out as illustrated by
Noudeh et al. [11]. Blood was collected from an adult sheep
(University of Zimbabwe Animal House). This study
was supported by the University of Zimbabwe Department
of Biochemistry Research Ethics Commitee (01. 11. 11,
UZBREC 02). Blood collected, was added to a 50 ml tube
containing 11 mM sodium citrate and immediately mixed
with an equal volume of Alsevier solution. Afterwards,
3 ml of the blood solution was centrifuged at 3000 rpm
for 10 min and the supernatant was removed and the
erythrocytes were washed three times in at least five times
of their volume with McIlvaine’s buffer (pH 7.0). Follow-
ing that, an erythrocyte suspension with 12% hematocrit
was prepared and kept in 4°C prior to use. A suspension
of erythrocytes (200 μl) was incubated with an equal vol-
ume of C. citrinus leaf extract or V. adoensis leaf extract
for 1 hour within a micro-tube, at 25 and 37°C. After incu-
bation, the mixture was centrifuged at 3000 rpm for 35 s
and 200 μl of the resulting supernatant was added to 3 ml
Figure 1 R6G uptake and IC50 of efflux pump inhibition activity
for A (reserpine), B (C. citrinus) and C (V. adoensis) against
P. aeruginosa.
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leased against the samples was determined using an ELISA
plate reader at 540 nm. Positive controls consisted of 200 μl
of uncentrifuged erythrocyte suspension and 200 μl of
McIlvaine’s buffer, which was added to 3 ml Drabkin’s re-
agent to obtain a value for 100% haemolysis. Additionally,
a negative control, included to measure the level of spon-
taneous haemolysis, was comprised of 200 μl McIlvaine’s
buffer mixed with 200 μl of the supernatant from centri-
fuged erythrocytes, and added to 3 ml of Drabkin’s reagent.
Haemolysis percentage for each sample was calculated by
dividing sample’s absorbance on positive control absorb-
ance (complete haemolysis) multiplied by 100.
Statistical analysis
One way ANOVA was used to analyse the results. All
values are expressed as the mean ± standard deviation and
P ≤ 0.05 values were considered to indicate statistically sig-
nificant differences. Numerical data were analysed using
the Student’s t-test using Graphpad™ version 5 for Windows
(Graphpad™ Software Inc., San Diego, California, USA).
Results
Measurement of R6G uptake
As shown in Figures 1A and 2A, reserpine exhibited the
lowest IC50 of 0.08 mg/ml and 0.04 mg/ml against
P. aeruginosa and S. aureus, respectively. On the other
hand, both extracts had similar EPI activity against
P. aeruginosa with an IC50 of 1.64 mg/ml (Figure 1B
and C). Following that, C. citrinus and V. adoensis leaf
extracts displayed an IC50 of 1.44 mg/ml and 1.61 mg/ml
against S. aueus, respectively. Although both plant ex-
tracts exhibited efflux pump inhibition, the activity
was lower than the standard plant-based EPI, reser-
pine. These observations showed that the leaf extract of
C. citrinus was more potent as an EPI than the V. adoensis
leaf extract against S. aureus. Additionally, the EPI
activity of both leaf extracts was comparable against
P. aeruginosa.
Cytoplasmic membrane permeability assay
Results from the cytoplasmic membrane permeability
assay, showed a gradual increase of diSC3-5 dye release
over time in the presence of both extracts of C. citrinus
and V. adoensis as well as in the presence of 1% DMSO
(Figure 3). At the end of a 60 minute monitoring period
against S. aureus, a 28% dye release was observed for
C. citrinus and 24% of the dye was release in the pres-
ence of V. adoensis. Furthermore, 21% of the diSC3-5 dye
was release by 1% DMSO. However, both plant extracts
were more potent as membrane permeability enhancers
against P. aeruginosa as compared to S. aureus. This is
shown by higher levels of dye released at 60 minutes
for both C. citrinus (53%) and V. adoensis (45%). TheP. aeruginosa membrane was also more sensitive to 1%
DMSO as compared to S. aueus sensitivity, with a 49%
dye release at 60 minutes (Table 1). There was no increase
in dye release overtime in the presence of ethanol which
was used a negative control. From the results there was
more diSC3-5 released from the P. aeriginosa membrane
as compared to the S. aureus membrane at the end of
60 minutes hence the Gram-negative membrane could be
easily permeabilized as compared to the Gram-positive
membrane for S. aureus. Overall, both C. citrinus and
Figure 2 R6G uptake and IC50 of efflux pump inhibition activity
for A (reserpine), B (C. citrinus) and C (V. adoensis) against
S. aureus.
Figure 3 Measurement of 3’3 dipropylthiadicarbocyanine (diSC3-5)
dye release overtime from S. aureus (A) and P. aeruginosa
(B) membranes in the presence of permeabilizing agent 1% DMSO,
negative control ethanol and plant extracts C. citrinus and
V. adoensis.
Table 1 Percentage increase of amount of dye being
released from bacterial membranes in the presence of
extracts of C. citrinus, for V. adoensis and DMSO after
60 mins
Sample % increase of dye released
at 60 mins S. aureus
% increase of dye released
at 60 mins P. aeruginosa
C. citrinus 28 53
V. adoensis 24 45
1% DMSO 21 49
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abilizing properties as shown by the increase in the per-
centage of dye leaking from the membrane with time.
Haemolysis assay
After being exposed to increasing concentrations of the
leaf extracts of C. citrinus and V. adoensis leaf extracts for
a period of 90 min, there was an increase in the amountof haemolysis in two different incubation temperatures
(Table 2). At 25°C, 39% haemolysis was observed up to a
concentration of 2.5 mg/ml for V. adoensis (Figure 4).
However, for concentrations greater than 2.5 mg/ml an
increase in haemolysis as concentration increases is ob-
served. For C. citrinus, less than 45% haemolysis was ob-
served at concentrations less than 1 mg/ml. At 37°C, less
than 40% haemolysis was observed at 1 mg/ml concentra-
tion of the leaf extract of C. citrinus, afterwhich complete
haemolysis of 100% was obtained at 2 mg/ml concentra-
tions. On the other hand, 29% haemolysis was observed
for the leaf extract of V. adoensis at 1 mg/ml, at 37°C
(Figure 4). However, rapid increase in haemolysis was de-
tected at more than 1 mg/ml against both extracts at
37°C. In addition, both extracts displayed 100% haem-
olysis at concentration more than 2.5 mg/ml. Results
Table 2 Haemolysis at different concentrations of plant extract at the end of a 90 minute incubation at 25°C and 37°C
Incubation temperature Plant sample % haemolysis 1 mg/ml % haemolysis 2.5 mg/ml % haemolysis 10 mg/ml
25°C C. citrinus 47 60 124
V. adoensis 36 37 119
37°C C. citrinus 40 110 93
V. adoensis 29 94 90
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was observed when the erythrocytes were incubated
at 37°C as compared to at 25°C. Moreover, at 25°C and
37°C, both extracts concentration of lower than 1.5 mg/ml
and 1 mg/ml did not harm the erythrocytes in an incuba-
tion period of 90 min, respectively.
Discussion
Inhibition of efflux pumps is increasingly becoming a
way to fight MDR micro-organisms. In this study, the IC50
values of EPI activities for the two plant extracts against
S. aureus and P. aeruginosa were determined. The IC50
values for the crude extracts were higher than the stand-
ard plant-based EPI, reserpine, which was used as the
positive control. This is most likely because the crude ex-
tracts have a mixture of a lot of other phytochemicals
which may be working antagonistically with the efflux
pump inhibition properties of unidentified compound/s in
the extracts. Further isolation and identification of EPI
compound/s from C. citrinus and V. adoensis leaf extracts
could increase the antibacterial activity. Many plants have
been evaluated not only for their inherent antimicrobialFigure 4 Extent of haemolysis of sheep erythrocytes with
increasing concentration of plant extracts at the end of a
90 minute incubation period at 25°C (A) and 37°C (B).activity, but also for their action as a resistant modifying
agent (RMA) [14-16]. Some plant-derived EPIs are already
well-known and used as standards such as reserpine
from Rauvolfia vomitoria and piperine from Piper nigrum
both of which are alkaloids [17,18]. Several other plant-
derived compounds, including the terpene carnosic acid
from Rosmarinus officinalis, the diterpene totarol from
Chamaecyparis nootkatensis, and the flavonolignan 5-
methoxyhydnocarpin, inhibits NorA efflux pump activity
in S. aureus and synergistically increases the activity of the
antimicrobial alkaloid berberine present in the same plant
[19]. Fiamegos et al. [5] and Garvey et al. [20] also demon-
strated efflux pump inhibition activity from plants.
Hence, isolation of phytoconstituents from the plants
could lead to potential EPIs comparable to the standard
inhibitors. The inhibition of drug transporters is one
form of modulation bacterial resistance to antimicrobial
drugs [21]. Effective bacterial EPIs should reduce the in-
trinsic resistance of bacteria to antibiotics, reverse any
acquired resistance and decrease the frequency of emer-
gence of resistant mutant strains [17]. Effective EPIs
could significantly improve antibiotic efficacy by raising
physiological levels of an antibiotic and act synergistic-
ally by reducing bacterial efflux [22].
Generally, the IC50 values of both leaf extracts were
lower against S. aureus (Figure 2) as compared for EPI
activities against P. aeruginosa (Figure 1). The difference
in susceptibility would most likely be due to the differ-
ence in architecture of the cell wall for Gram-positive
and Gram-negative bacterial species. Gram-negative bac-
teria are generally known to be more resistant to antibac-
terials due to the double membrane while Gram positive
bacteria are more sensitive to antibacterial agents because
of the single layer which is not too difficult to penetrate
[23-25]. However, the findings in this study showed
both P. aeruginosa and S. aureus were sensitive against V.
adoensis extract with comparable IC50 values of 1.64 mg/ml
and 1.61 mg/ml, respectively. On the other hand, S. aureus
was even more sensitive against C. citrinus with an IC50
value of 1.44 mg/ml, than P. aeruginosa which had an IC50
value of 1.64 mg/ml against C. citrinus. This could be at-
tributed to the fact that S. aureus has a single membrane
providing easy passage of the EPI while P. aeruginosa has a
double membrane. These results concur with an earlier
study that displayed comparable MIC values of both plant
extracts against both bacteria [11].
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using the membrane-potential-sensitive cyanine dye
diSC3-5. This dye is known to distribute between bacterial
cells and the surrounding medium, depending on the mem-
brane potential gradient [4]. Once inside the membrane,
the dye aggregates and self-quenches. With the addition
of a membrane-permeabilizing agent, dye is released and
the increase of fluorescence monitored over time. In this
experiment, the cell membranes of S. aureus and P. aeru-
ginosa were loaded with the diSC3-5 dye and exposed to
the plant extracts over a period of time. An increase in
fluorescence was observed for both plants extracts sug-
gesting the presence of permeabilising properties in the
plant extracts. Some plant extracts have been shown in
other studies to cause membrane permeability [10].
Most active plants are toxic at high doses and it is there-
fore important to investigate the preliminary toxicity of
plant extracts [26]. This study is essential in order to deter-
mine dosage of the plant extracts which will not be lethal
to the body when administered. The findings showed that
haemolytic activity of extracts of the tested plants increased
as concentration of the extracts arose. The increase ob-
served was in a dose-dependent manner. According to
Fick’s law, diffusion flux from a membrane is proportional
to concentration difference of both sides [10]. Hence, by
increasing the concentration of the extracts in extra mem-
brane, it diffuses to intra membrane until it gets to a spe-
cific concentration, which leads to membrane destruction
and haemolytic effects [10]. The haemolytic activity of the
plant extracts were also shown to increase as temperature
arose from 25°C to 37°C. This can be attributed to the flu-
idity of the bi-lipid layer of the cell membrane in which
some parts of the membrane can easily move throughout
the surface and this characteristic is due to membrane
phospholipids which convert to jelly in temperatures
lower than physiologic temperature [10]. From this study
it is important to determine the levels of the leaf extracts
that may be toxic to the body.
Conclusion
Based on this study, we concluded that both C. citrinus
and V. adoensis extracts have potential antibacterial ac-
tivities in the form of EPI as well as cytoplasmic mem-
brane permeabilising phytochemicals. On the other hand
effective permeabilizing agents could be used to speed
up the accessibility of antibiotics to targets within the
bacterial cells. C. citrinus and V. adoensis leaf extracts
thus have the potential to provide new lead compounds
for the development of new antibiotics, efflux pump in-
hibitors and bacterial membrane permeabilizing agents
for the treatment of S. aureus and P. aeruginosa infec-
tions. Current work is being carried out to further isolate
and purify phytochemicals with antibacterial activity
from both plant extracts.Additional information
Buffer and reagents preparation for the haemolysis assay.
McIlvaine’s buffer was prepared as follows: solution 1,
containing 21 g of citric acid (100 mM) and 8.775 g of so-
dium chloride (150 mM) made up to 1000 ml with deion-
ized water, was mixed with solution 2, containing 28.4 g of
di-sodium hydrogen phosphate (200 mM) and 8.775 g of
sodium chloride (150 mM) made up to 1000 ml with de-
ionized water, to produce the required pH of 7.0. Drab-
kin’s reagent was prepared by adding 1 g of sodium
hydrogen carbonate, 0.2 g of potassium ferricyanide and
0.05 g of potassium cyanide in 1 litre of distilled water.
Alsever solution was prepared by adding 0.05 g of glucose,
0.80 g Na-citrate and 0.42 g sodium chloride in 100 ml of
bi-distilled water.
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